← Back to Search

Virtual Intensive Outpatient Program for Alcoholism

N/A
Recruiting
Led By Matthew Sloan, MD
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to communicate and provide informed consent in English
≥ 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights

Study Summary

This trial aims to offer a virtual intensive outpatient program for people with alcohol use disorder to help them reduce their drinking and improve their health.

Who is the study for?
This trial is for English-speaking adults over 18 with moderate to severe alcohol use disorder who are motivated to abstain from alcohol. Participants must attend daily virtual sessions on weekdays and take multiple breathalyzer readings each day. They need private space and OHIP coverage but can't join if they have a history of severe withdrawal, certain medical or psychiatric conditions, concurrent substance use disorders, or plans to be out of the province.Check my eligibility
What is being tested?
The study tests a 4-week virtual intensive outpatient program designed to help people with alcohol use disorder stop drinking. It includes group and individual therapy sessions conducted online, aiming to mimic residential treatment programs' structure and monitoring while participants remain at home.See study design
What are the potential side effects?
Since this is a behavioral intervention focusing on abstinence through virtual therapy rather than medication, typical drug side effects are not expected. However, participants may experience stress or emotional discomfort related to discussions during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can speak and understand English well enough to give informed consent.
Select...
I am 18 years old or older.
Select...
I can attend all sessions and do daily breathalyzer tests for the program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Retention in treatment
Satisfaction with treatment as assessed by the Client Satisfaction Questionnaire-8 (CSQ-8)
Secondary outcome measures
Change in Anxiety Symptoms during the IOP Assessed Using the Generalized Anxiety Disorder-7 (GAD-7)
Change in Depressive Symptoms during the IOP Assessed Using the Patient Health Questionnaire-9 (PHQ-9)
Change in Emotion Regulation During the IOP Assessed Using the Difficulties in Emotion Regulation Scale (DERS)
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual Intensive Outpatient ProgramExperimental Treatment1 Intervention
Participants will be treated in a 4 week program involving daily psychotherapy groups, weekly individual therapy and medication management, as well as daily breathalyzer monitoring.

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,336 Previous Clinical Trials
25,751,045 Total Patients Enrolled
5 Trials studying Alcoholism
780 Patients Enrolled for Alcoholism
Centre for Addiction and Mental HealthLead Sponsor
351 Previous Clinical Trials
80,753 Total Patients Enrolled
16 Trials studying Alcoholism
3,442 Patients Enrolled for Alcoholism
Matthew Sloan, MDPrincipal InvestigatorCentre for Addiction and Mental Health
1 Previous Clinical Trials
400 Total Patients Enrolled
1 Trials studying Alcoholism
400 Patients Enrolled for Alcoholism

Media Library

Virtual Intensive Outpatient Program Clinical Trial Eligibility Overview. Trial Name: NCT05722483 — N/A
Alcoholism Research Study Groups: Virtual Intensive Outpatient Program
Alcoholism Clinical Trial 2023: Virtual Intensive Outpatient Program Highlights & Side Effects. Trial Name: NCT05722483 — N/A
Virtual Intensive Outpatient Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05722483 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative currently open to participants?

"Clinicaltrials.gov states that this research endeavor is presently recruiting participants, having initially been posted on January 30th 2023 and recently revised as of February 1st 2023."

Answered by AI

How many individuals are currently undergoing this clinical research?

"Affirmative. According to the information shared on clinicaltrials.gov, recruitment for this medical study is open and ongoing since its posting date of January 30th 2023. It requires 63 participants from a single site and has most recently been updated on February 1st 2023."

Answered by AI
~25 spots leftby Dec 2024